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Causes of Arterial Bleeding After Living
Donor Liver Transplantation and the
Results of Transcatheter Arterial
Embolization
Objective: To analyze the causes of arterial bleeding after living donor liver
transplantation (LDLT) and to evaluate the efficacy of transcatheter arterial
embolization (TAE).
Materials and Methods: Forty-two sessions of conventional arteriography
were performed in 32 of the 195 patients who underwent LDLT during the past 2
years. This was done in search of bleeding foci of arterial origin. TAE was per-
formed with microcoils or gelatin sponge particles. The causes of arterial bleed-
ing, the technical and clinical success rates of TAE and the complications were
retrospectively evaluated.
Results: Forty-two bleeding foci of arterial origin were identified on 30 ses-
sions of arteriography in 21 patients. The most common cause of bleeding was
percutaneous procedures in 40% of the patients (17 of the 42 bleeding foci) fol-
lowed by surgical procedures in 36% (15/42). The overall technical and clinical
success rates of TAE were 21 (70%) and 20 (67%) of the 30 sessions, respec-
tively. The overall technical success rate of TAE for the treatment of bleeding
from the hepatic resection margin, hepatic artery anastomotic site and hepatico-
jejunostomy was only 18% (2/11), whereas for the treatment of bleeding in the
other locations the technical and clinical success rates of TAE were 100% and
95%, respectively. No procedure-related major complications occurred.
Conclusion: In the case of arterial bleeding after LDLT, percutaneous proce-
dure-related hemorrhages were as common as surgery-related hemorrhages.
There were technical difficulties in using TAE for the treatment of hepatic arterial
bleeding. However, in the other locations, TAE seems to be safe and effective for
the control of arterial bleeding in LDLT recipients.
he first successful case of living donor liver transplantation (LDLT) was
performed by Raia et al. in 1989 (1). In spite of its short history, the
difficulties associated with cadaveric donations and serious donor
shortages have led to the development and popularization of LDLT (2, 3). In contrast
to the other types of major abdominal surgery, LDLT is associated with several
specific situations in which arterial bleeding is likely to occur. In effect, LDLT
generates a liver graft with a cut surface of variable size and multiple anastomotic sites
that are potential sources of bleeding after revascularization (4). In addition, in spite of
the refinements that have been made in the medical and surgical techniques, all liver
transplantation recipients have some degree of coagulopathy, especially during the
perioperative period, as a result of their underlying liver disease (4 6).
Although its incidence and mortality rate have not been precisely determined,
arterial bleeding after liver transplantation has sporadically been reported to be an
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Tobvious cause of death (4 15). To our knowledge, there
has been little published data about post-transplant
hemorrhage, its diagnosis with angiography and
subsequent treatment with embolization. It seems that
most cases of arterial bleeding following liver transplanta-
tion have been treated primarily by repeat surgery (4, 6).
At our institution, transcatheter arterial embolization
(TAE) has been the first step in the control of presumptive
post-transplant arterial bleeding for the past several years.
The aims of this retrospective study are to analyze the
etiology of arterial bleeding foci in LDLT recipients and to
evaluate the efficacy of TAE.
MATERIALS AND METHODS
Patient Population
Between April 1999 and March 2001, 32 (26 men and 6
women; age range, 7 62 years; mean age, 43 years) of
195 patients who had undergone LDLT underwent 42
sessions of conventional arteriography in search of
bleeding foci of arterial origin within 6 months of the
operation. Arterial bleeding was suspected clinically if the
symptoms or signs were as follows: abnormally increased
drainage of fresh blood through the Jackson-Pratt (JP) tube
in 26 sessions, hematochezia or melena in 8 sessions,
hemothorax or hemoptysis in 5 sessions, hemobilia in 2
sessions, or an acute decrease in the hemoglobin level in
one session. Six patients underwent two or three sessions
of arteriography or TAE, because of recurrent arterial
bleeding. However, the bleeding foci were different in
each of the sessions conducted for the same patient. In all
patients, the arterial bleeding occurred within two months
(mean, 14 days; range, 1 56 days) after LDLT.
Arteriography was performed within three days (mean, 1
day) after the detection of arterial bleeding, depending on
the patient’s condition.
The underlying causes of hepatic failure and LDLT in
these 32 patients were hepatitis B-related liver cirrhosis
with or without hepatocellular carcinoma (n=29),
secondary biliary cirrhosis due to intrahepatic stones
(n=1), fatal fulminant hepatitis due to Wilson’s disease
(n=1), and biliary atresia (n=1). The grafts involved in the
LDLT included the right lobe (n=21), left lobe (n=8), dual
left lobe (n=2), and left lateral segment (n=1).
Conventional Arteriography and Transcatheter
Arterial Embolization
In all patients, informed consent was obtained from the
patient or the patient’s family prior to arteriography. Once
the right or left femoral artery was punctured, a 5-F end-
hole catheter was introduced over a 0.035-inch guide wire
(Terumo; Radiofocus, Tokyo, Japan). Following the
superior mesenteric and common hepatic arteriographies,
which were performed to evaluate the patency of the
portal and hepatic arterial anastomoses and potential
bleeding foci, the suspected arteries destined for selective
arteriography were selected. A provisional identification of
the bleeding arteries was made based on the patient’s
symptoms or signs, radiological findings, including dynamic
CT and RBC scans, and the surgical information obtained
during LDLT.
In the patients with abnormally increased drainage of
fresh blood through the JP tube, selective arteriographies
were performed of several specific arteries, for which the
arterial bleeding might be stagnant in the JP tube placed
area. In those patients with hematochezia or melena,
inferior mesenteric or left gastric arteriography was
performed following superior mesenteric and common
hepatic arteriographies, according to the available clinical
information. In those patients with hemothorax or hemopt-
ysis, selective arteriographies of the inferior phrenic artery,
intercostal arteries adjacent to the pleural drain tubes,
subclavian artery and/or bronchial artery were performed
according to the available clinical information.
Aortography for the purpose of gaining an understanding
of the arterial anatomy prior to selective arteriography was
not routinely performed. However, aortography was
performed to rule out the possible of there being any
missed bleeding foci, if the selective arteriographies of the
presumptive arteries did not demonstrate any active
bleeding foci.
If the bleeding foci were present on the arteriograms,
then either TAE or surgery was undertaken to control the
bleeding, subject to the mutual agreement of the surgeons
and interventional radiologists. TAE was intended to be
the primary treatment, however, surgical management was
considered as the primary treatment if the bleeding foci
were technically too difficult or dangerous to be
embolized, such as in the case of a hepatic arterial anasto-
motic site or hepatic resection margin.
For TAE, the bleeding arteries were superselected using
a 3F-microcatheter (Microferret; Cook, Bjaerverskov,
Denmark) and embolized with 0.018-inch-Hilal microcoils
(Cook, Bloomington, U.S.A.) or 0.018-inch-Tornado
microcoils (Cook, Bloomington, U.S.A.). Gelatin sponge
particles (Gelfoam; Upjohn, Kalamazoo, MI) were also
used in the case of several specific arteries (intercostal,
inferior phrenic and epigastric arteries) prior to emboliza-
tion using microcoils, to minimize any rebleeding from
collateral vessels.
If the bleeding foci were absent on the selective arteri-
ograms and aortogram, explorative laparotomy or clinical
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patient’s condition.
Analysis
In all patients, a complete retrospective review of the
medical and surgical records and radiological imaging were
performed. The following items were documented
retrospectively: the presumptive causes and locations of
arterial bleeding, the technical and clinical success rates of
TAE, and the complications.
A bleeding focus was defined as an extravasation of the
contrast media or a pseudoaneurysm that was a likely
cause of bleeding. The arterial bleeding was divided into
four categories according to the possible related causes:
Surgical bleeding was defined as an arterial bleeding
related to the LDLT itself and included bleeding from the
hepatic resection margin, hepatic arterial anastomotic site,
incision wounds, and the hepaticojejunostomy site.
Iatrogenic bleeding was defined as bleeding associated with
percutaneous invasive procedures, such as transhepatic
biliary drainage, central venous access and chest tube
insertion. Spontaneous bleeding was defined as bleeding
that developed spontaneously, such as gastrointestinal
bleeding remote from the hepaticojejunostomy site. Non-
classifiable bleeding was defined as bleeding that was not
able to be classified properly.
The technical success of TAE was defined as the
complete disappearance of arterial bleeding following
TAE. Technically impossible or incomplete embolization
was regarded as technical failure. Clinical success was
defined as an amelioration of the presenting signs or
symptoms of arterial bleeding following TAE. Major
complications were defined as those necessitating an
increased level of care, surgery, prolonged hospital stay,
Kim et al.
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Table 1. Distribution of Arterial Bleeding Foci and Technical
Success Rates of Transcatheter Arterial
Embolization for Each Bleeding Foci
Bleeding Foci
Transcatheter Arterial Embolization
S F S + F TSR (%)
HA
IHA 03 03 100
HAAS 012 03 033
HRM 014 05 020
HJS 3 03 000
ICA 11 11 100
IPA 06 06 100
SCA 04 04 100
SMAJ 03 03 100
PDA 02 02 100
EIA 02 02 100
Total 33 9 42 079
Note. S = technical success, F = technical failure, TSR = technical
success rate, HA = hepatic artery, IHA = intrahepatic artery, HAAS =
hepatic artery anastomotic site, HRM = hepatic resection margin, HJS =
hepaticojejunostomy site, ICA = intercostal artery, IPA = inferior phrenic
artery, SCA = thoracic branch of subclavian artery, SMAJ = jejunal branch
of superior mesenteric artery, PDA = pancreaticoduodenal arcade, EIA =
branch of external iliac artery
Fig. 1. A 48-year-old man presenting with an abruptly increased amount of fresh blood draining from a Jackson-Pratt drain. Two weeks
previously, he underwent stent placement because of portal vein stenosis.
A. Common hepatic arteriogram shows a pseudoaneurysm (arrow) supplied by the segment V hepatic artery.
B. The supplying hepatic artery was successfully embolized with microcoils. After embolization, the patient clinically improved.
ABpermanent adverse sequelae or death. All other complica-
tions were defined as minor complications.
RESULTS
Causes and Locations of Arterial Bleeding
Conventional arteriography demonstrated 42 bleeding
foci of arterial origin in 30 sessions (23 patients). The
number of bleeding foci detected were one in 22 sessions
(15 patients), two in six sessions (6 patients), and more
than three in two sessions (2 patients). The distribution of
the bleeding foci is shown in Table 1. The bleeding foci
originated most frequently from the hepatic artery (14/42,
33%) and intercostal artery (11/42, 26%).
Based on a complete review of the clinical, interven-
tional and surgical data, the bleeding foci were classified
into 4 categories corresponding to the most likely causes of
arterial bleeding (Table 2). In this way, it was
demonstrated that, in addition to surgical bleeding (36%),
iatrogenic bleeding (40%) was also a major cause of
arterial bleeding after LDLT.
Transcatheter Arterial Embolization
TAE was technically successful in 33 of the 42 foci of
active arterial bleeding (Table 1) (Figs. 1, 2). However,
TAE failed in the remaining 9 foci of active arterial
bleeding, due to technically difficult superselection of the
corresponding bleeding artery or the potential high risk
associated with TAE (Fig. 3). These bleeding foci consisted
of hepatic artery anastomotic sites (n=2), hepatic resection
margins (n=4) and hepaticojejunostomies (n=3), and they
were treated by surgery.
Embolization was completed in 21 sessions (Table 3).
However, in three sessions, additional immediate surgery
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Table 2. Classification of Presumptive Causes of Arterial
Bleeding After Living Donor Liver Transplantation
Possible Causes of Arterial Bleeding              No of Foci
Surgical 15 (36%)
Hepatic resection margin 05
Hepaticojejunostomy site 04
Hepatic artery anastomotic site 03
Abdominal surgical wound 02
Jackson-Pratt drain placement 01
Iatrogenic 17 (40%)
Chest tube placement 11
Central venous catheterization 03
Percutaneous transhepatic biliary drainage 02
Portal vein stent placement 01
Spontaneous 3 (7%)
Gastrointestinal bleeding 03
Non-classifiable 7 (17%)
Inferior phrenic artery  06
Intrahepatic artery 01
Total 42 (100%)
Fig. 2. A 47-year-old woman with arterial bleeding through a Jackson-Pratt drain.
A. Right 10th intercostal arteriogram shows extravasation of contrast media (arrow).
B. Right 10th intercostal artery was embolized with gelfoam particles and microcoils. After embolization, the stain disappeared. The
patient clinically improved.
ABhad to be conducted following successful TAE for the
evacuation of hematoma. However, there was no evidence
of active arterial bleeding in the operation field in any of
these cases. In 20 of the 21 sessions, the patients showed a
clinical improvement in the active arterial bleeding after
successful TAE. One patient did not show any clinical
improvement, because of recurrent arterial bleeding of the
same focus. This patient had been treated by anti-coagula-
tion therapy due to cerebral infarction, resulting in a
severe iatrogenic bleeding tendency, and died of multifocal
hemorrhage including cerebral hemorrhage several days
after TAE. The overall technical and clinical success rates
for the 30 sessions of TAE were 21 (70%) and 20 (67%),
respectively. These relatively low success rates can be
ascribed to the three bleeding foci (hepatic resection
margins, hepatic artery anastomotic sites and hepaticoje-
junostomy sites), in which embolization was either
incomplete or impossible. In the case of the three bleeding
foci, the technical success rate was only 2 (18%) out of 11
sessions. If these bleeding foci were excluded, the overall
technical and clinical success rates were 19 (100%) and 18
(95%) out of 19 sessions.
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Fig. 3. A 47-year-old man presenting with arterial bleeding through a Jackson-Pratt drain.
A. Common hepatic arteriogram shows extravasation of contrast media (arrow).
B. A branch of the supplying hepatic artery was embolized with a straight microcoil.
C. Post-embolization hepatic arteriogram shows residual stain fed from fine collateral vessels.
D. Immediately after embolization, CT shows collection of contrast media along the hepatic resection margin. Afterwards, the patient
underwent additional surgery to control the residual bleeding.
CD
ABSix (19%) patients underwent two or three sessions of
arteriography, because of recurrent arterial bleeding.
However, different bleeding foci were treated in each
session of arteriography conducted for the same patient.
Recurrent bleeding at the same foci was present in only
one patient, as described above.
On the other hand, arteriography showed no active
bleeding focus in 12 sessions (11 patients). These cases
were managed either by surgery (6 patients) or close
clinical observation (5 patients) with transfusion, depend-
ing on the patient’s condition. In three of the former six
patients, surgery allowed the discovery of active arterial
bleeding at the hepatic artery anastomotic site (n=1),
hepatic resection margin (n=1), and venous oozing (n=1)
at the anastomosis of the hepatic vein and vena cava.
However, a retrospective review of the selective
angiographic images of these patients did not demonstrate
the presence of any bleeding focus. In the remaining three
patients, surgery did not lead to the discovery of any
bleeding focus, and they only underwent hematoma
evacuation. After either conservative or surgical manage-
ment, the signs of active bleeding ameliorated in all 11
patients.
During the 6 month follow-up period after LDLT, there
were no major TAE-related complications.
DISCUSSION
According to our results, arterial bleeding after LDLT
was not confined to surgical causes. Surgical bleeding was
one of the most common causes of bleeding after LDLT,
however, iatrogenic bleeding was even more common than
surgical bleeding in our retrospective study. Coagulopathy
after LDLT is inevitable for a certain period of time in
most liver transplant recipients, until the graft’s function is
normalized. The risk of iatrogenic bleeding is also high in
the early post-LDLT period. Thus, clinicians should make a
particular effort to prevent iatrogenic bleeding during
percutaneous procedures after LDLT.
Some amount of surgical bleeding from the hepatic
artery at the hepatic arterial anastomotic site, hepatic
resection margin or hepaticojejunostomy site is inevitable,
because LDLT generates a liver graft with variable-sized
cut surfaces and multiple anastomotic sites. In fact,
bleeding from the hepatic artery was the most common
cause of bleeding in our study. However, performing TAE
in the case of bleeding from the hepatic artery following
LDLT was virtually impossible, because of the difficulty
involved in the superselection of the bleeding arteries, due
to the existence of fine arterial feeders, hepatic arterial
anastomotic stenosis, a tortuous arterial course or multifo-
cal occurrences. Furthermore, performing TAE of the
hepatic artery runs the risk of hepatic infarction or failure
following inadvertent diffuse proximal embolization (16).
Marshall et al. (17) reported that three of nine patients
with extrahepatic pseudoaneurysm following liver
transplantation underwent effective coil embolization,
however all patients subsequently underwent retransplan-
tation due to graft ischemia.
Accordingly, we achieved technical success in only four
of the 14 foci involving bleeding from the hepatic arterial
branches. Although TAE can be performed in some
patients with massive bleeding from the hepatic artery, we
consider that surgical management is the treatment of
choice for the management of surgically induced bleeding
from the hepatic artery anastomotic site, hepatic resection
margin or hepaticojejunostomy site.
The next most frequently bleeding arteries were the
intercostal and inferior phrenic arteries. The cause of
bleeding from the intercostal artery was iatrogenic
bleeding in most cases, resulting from either placement of a
drain tube or central venous catheterization. The cause of
bleeding from the inferior phrenic artery was uncertain,
however it might have been related to various causes, such
as intraoperative retractor injury, chest tube insertion or
spontaneous bleeding, and it must be routinely evaluated
to rule out active bleeding.
Knowledge of the clinical symptoms or signs of arterial
bleeding provided by the clinicians is very helpful prior to
the performance of arteriography. A JP drain was the most
common clinical clue to the presence of arterial bleeding
after LDLT. A lot of arteries are involved in this type of
manifestation. Bleeding can occur from the hepatic,
intercostal, inferior phrenic or pancreaticoduodenal
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Table 3. Technical and Clinical Success Rate of
Transcatheter Arterial Embolization on All 30
Sessions
Treatment Session TS CS
TAE(C) 17 (15)* 17 (15)* 17 (15)*
TAE (C) + Surgery 4 (4)* 4 (4)* 3 (3)*
TAE (I) + Surgery 3 (0)*
Surgery 6 (0)*
Total 30 (19) 21 (19) 20 (18)
Success Rate 70% (100%) 67% (95%)
TAE = transcatheter arterial embolization, TS = technical success, CS =
clinical success, TAE (C) = complete embolization, TAE (I) = incomplete
embolization
*Parentheses means the changed values when three bleeding foci
(hepaticojejunostomy site, hepatic arterial anastomotic site, and hepatic
resection margin) were excluded.Kim et al.
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arteries or from the jejunal branches of the superior
mesenteric artery. Unusually, bleeding from the deep
circumflex iliac and inferior epigastric arteries was
manifested as JP bleeding in one case. Therefore, in our
opinion, arteriograms of the inferior phrenic and
intercostals arteries, as well as of the superior mesenteric
and common hepatic arteries, should be surveyed in cases
of JP drain bleeding. In addition, those arteries supplying
the lower thoracic and abdominal walls should also be
considered as possible sources of arterial bleeding.
As in the case of general surgical patients, LDLT recipi-
ents are also subject to bleeding from stress ulceration,
peptic ulcer and angiodysplasia of the colon (4, 6, 18). Not
uncommonly, this bleeding tends to be resolved only by
proper medical treatment (4). Clinical observation may be
sufficient whenever the patient’s condition tolerates it. In
our study, four patients with hematochezia or melena
showed negative outcomes on arteriography, but improved
clinically without surgery or TAE. In fact, TAE was very
effective in cases of positive arteriography, and all four
patients with arteriographically proven gastrointestinal
bleeding improved after only one session of TAE.
In the conventional arteriogram, a negative outcome
does not always guarantee the absence of actual bleeding.
In our study, surgery demonstrated active bleeding foci in
three of six patients without active bleeding on selective
arteriography. This discrepancy seems to have been caused
by minor or intermittent arterial bleeding or venous
oozing. In contrast, surgery did not lead to the detection of
any bleeding focus in the three remaining patients.
In conclusion, percutaneous procedures constituted one
of the major causes of post-LDLT arterial bleeding.
Therefore, extra caution should be taken in LDLT patients.
Technical limitations were encountered when using TAE
for the management of hepatic arterial bleeding. However,
in the other locations, TAE seems to be effective and safe
for the control of arterial bleeding after LDLT.
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